Accelerating AAV Vectors for CNS Disorders

Time: 4:30 pm
day: Day One

Details:

• Review current serotypes that can be applied in neurological disorders
• Capturing the methods to improve transduction efficiency
• Current status of enabling AAV to cross BBB